Pimavanserin 34 mg Capsule clinical trials

A 52-Week Open-Label Extension Study of Pimavanserin in Children and Adolescents with Irritability Associated with Autism Spectrum Disorder (ASD)

This study is looking at a medicine called Pimavanserin for children and teenagers with autism who experience irritability. It's an open-label study, meaning everyone knows they're getting the medicine. The main focus is checking for any side effects over a year.